In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Percutaneous Transforamen Ovale Biopsy: An Institutional Series and Relative Contraindications

    Final Number:
    1707

    Authors:
    Joshua David Hughes MD; Michael J. Link MD; John L. D. Atkinson MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: Percutaneous transforamen ovale biopsy(PTC-TFOB) is a possible alternative to open cranial biopsy for lesions of the cavernous sinus(CS) and Meckel’s cave(MC). However, there is only one prior study on PTC-TFOB’s diagnostic utility.

    Methods: An electronic search of operative records found 15 PTC-TFOB performed in 13 patients at our institution from 1999–2012. All procedures used CT or fluoroscopic guidance. Records were reviewed for patient and imaging characteristics and diagnostic outcome.

    Results: Median age was 61(31–80) years. The most common presenting symptom was trigeminal nerve pain or numbness in 10 patients. Eight patients had left- and 5 had right-sided biopsy. There were no complications. Diagnostic tissue was obtained in 7(54%) patients and included meningioma(n=3), adenocarcinoma(n=1), adenocystic carcinoma(n=1), metastatic melanoma(n=1), and neurosarcoidosis(n=1). One patient had a non-diagnostic biopsy, but a second was diagnostic. All patients had a mass lesion with a median size of 2.4(1.5–3.3)cm that clearly involved the foramen ovale. Six(46%) patients had a non-diagnostic biopsy. All non-diagnostic tissue showed nerve fibers indicating correct location. Four patients had abnormal enhancement of the V3 division of the trigeminal nerve and were ultimately diagnosed with lymphoma(n=2) and metastatic squamous cell carcinoma(n=2) by open cranial(n=2), facial nerve(n=1), or skin lesion(n=1) biopsy. One patient had CS enhancement, but only patchy enhancement over the foramen ovale and was diagnosed with an inflammatory condition after symptom and imaging resolution. One patient had a 4.8 cm CS mass and questionable foramen ovale involvement. Open cranial biopsy showed lymphoma.

    Conclusions: In our series of 13 patients, PTC-TFOB obtained diagnostic tissue in 54%. This is the second largest reported series. We recommend PTC-TFOB for mass lesions that are clearly accessible by the foramen ovale. Lesions that only caused V3 enhancement or had questionable involvement of the foramen ovale were all non-diagnostic in our series.

    Patient Care: This research clarifies when percutatnous transforamen ovale biopsy is likely to yield diagnostic results and when it is likely to fail.

    Learning Objectives: By the end of this session participants should be able to understand when percutaneous transforamen ovale biopsy is likely to yield diagnostic tissue

    References: Messerer, Mahmoud, et al. "Percutaneous biopsy of lesions in the cavernous sinus region through the foramen ovale: diagnostic accuracy and limits in 50 patients: Clinical article." Journal of neurosurgery 116.2 (2012): 390-398.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy